Greatmark Investment Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.4M | Sell |
110,539
-5,120
| -4% | -$457K | 1.26% | 25 |
|
|
2026
Q1 | $8.31M | Sell |
115,659
-2,052
| -2% | -$158K | 0.97% | 30 |
|
|
2025
Q4 | $9.34M | Sell |
117,711
-4,080
| -3% | -$322K | 1.1% | 29 |
|
|
2025
Q3 | $9.18M | Sell |
121,791
-3,070
| -2% | -$210K | 1.1% | 28 |
|
|
2025
Q2 | $8.61M | Sell |
124,861
-1,642
| -1% | -$108K | 1.08% | 29 |
|
|
2025
Q1 | $8.57M | Sell |
126,503
-1,760
| -1% | -$105K | 1.17% | 28 |
|
|
2024
Q4 | $5.76M | Sell |
128,263
-178,639
| -58% | -$10M | 0.78% | 36 |
|
|
2024
Q3 | $19.3M | Buy |
306,902
+11,072
| +4% | +$646K | 2.62% | 13 |
|
|
2024
Q2 | $17.5M | Buy |
295,830
+22,703
| +8% | +$1.42M | 2.55% | 13 |
|
|
2024
Q1 | $21.8M | Buy |
273,127
+11,999
| +5% | +$917K | 3.1% | 8 |
|
|
2023
Q4 | $20.6M | Buy |
261,128
+9,868
| +4% | +$702K | 3.23% | 9 |
|
|
2023
Q3 | $17.5M | Buy |
251,260
+12,750
| +5% | +$903K | 3.1% | 7 |
|
|
2023
Q2 | $16.5M | Buy |
238,510
+24,724
| +12% | +$1.76M | 2.78% | 9 |
|
|
2023
Q1 | $15.9M | Buy |
213,786
+5,099
| +2% | +$428K | 2.83% | 11 |
|
|
2022
Q4 | $19.4M | Sell |
208,687
-4,984
| -2% | -$481K | 3.56% | 7 |
|
|
2022
Q3 | $20.4M | Buy |
213,671
+1,681
| +0.8% | +$166K | 3.93% | 6 |
|
|
2022
Q2 | $19.6M | Buy |
211,990
+2,904
| +1% | +$283K | 3.77% | 5 |
|
|
2022
Q1 | $21.2M | Sell |
209,086
-915
| -0.4% | -$96.1K | 3.48% | 9 |
|
|
2021
Q4 | $21.7M | Sell |
210,001
-149
| -0.1% | -$13.8K | 3.64% | 6 |
|
|
2021
Q3 | $17.8M | Buy |
210,150
+2,487
| +1% | +$208K | 3.34% | 8 |
|
|
2021
Q2 | $17.3M | Buy |
207,663
+2,416
| +1% | +$198K | 3.13% | 9 |
|
|
2021
Q1 | $15.4M | Sell |
205,247
-418
| -0.2% | -$30.4K | 3.02% | 9 |
|
|
2020
Q4 | $14M | Sell |
205,665
-1,244
| -0.6% | -$80.9K | 3.04% | 10 |
|
|
2020
Q3 | $12.1M | Buy |
206,909
+6,921
| +3% | +$431K | 3.04% | 11 |
|
|
2020
Q2 | $13M | Sell |
199,988
-2,024
| -1% | -$127K | 3.42% | 8 |
|
|
2020
Q1 | $12M | Buy |
202,012
+3,145
| +2% | +$210K | 3.85% | 5 |
|
|
2019
Q4 | $14.8M | Buy |
198,867
+5,391
| +3% | +$379K | 3.65% | 7 |
|
|
2019
Q3 | $12.2M | Buy |
193,476
+9,571
| +5% | +$567K | 3.34% | 7 |
|
|
2019
Q2 | $10M | Buy |
183,905
+45,890
| +33% | +$2.47M | 2.99% | 10 |
|
|
2019
Q1 | $7.44M | Buy |
138,015
+20,940
| +18% | +$1.29M | 2.35% | 14 |
|
|
2018
Q4 | $7.67M | Buy |
117,075
+39,475
| +51% | +$2.95M | 2.75% | 12 |
|
|
2018
Q3 | $6.11M | Buy |
77,600
+7,480
| +11% | +$535K | 1.92% | 19 |
|
|
2018
Q2 | $4.51M | Buy |
70,120
+42,735
| +156% | +$2.82M | 1.56% | 24 |
|
|
2018
Q1 | $1.7M | Buy |
+27,385
| New | +$1.96M | 0.62% | 39 |
|
Other funds holding CVS
Greatmark Investment Partners's CVS Position: Q2 2026 in Review
Greatmark Investment Partners reduced its CVS Health (CVS) stake by 4.4% in Q2 2026, selling an estimated $457K and leaving 110,539 shares worth $11.4M. The position accounts for 1.26% of the portfolio, ranked #25.
Greatmark Investment Partners first reported a position in CVS in Q1 2018 and has held it in 34 quarters since. The position peaked at $21.8M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Greatmark Investment Partners held 110,539 shares of CVS Health worth $11.4M as of Q2 2026.
- Greatmark Investment Partners sold 5,120 CVS Health shares in Q2 2026, an estimated $457K.
- CVS Health made up 1.26% of Greatmark Investment Partners's portfolio in Q2 2026, its #25 holding.
- Greatmark Investment Partners first reported a position in CVS Health in Q1 2018 and has held it in 34 quarters since.
- Greatmark Investment Partners's CVS Health position peaked at $21.8M in Q1 2024.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Greatmark Investment Partners's 13F filing for Q2 2026, filed 24 Jul 2026.